FOR vs MRNA · P/E 8.7, rev $1.66B vs rev $1.94B
Forestar Group Inc (FOR) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Forestar Group Inc (FOR) is a real estate - development company listed on NYSE.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported FOR revenue for 2025-09-30 was $1.66B. Net income was $167.9M. Revenue was up 10.1% from 2024-09-30 to 2025-09-30. FOR currently screens at market cap $1.45B and trailing P/E 8.7.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
FOR currently screens at market cap $1.45B and trailing P/E 8.7. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the FOR and MRNA stock pages for the full models.
Not investment advice.